HomeCompareAVLP vs MRK

AVLP vs MRK: Dividend Comparison 2026

AVLP yields 500000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVLP wins by $4.663521010693878e+33M in total portfolio value
10 years
AVLP
AVLP
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full AVLP calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — AVLP vs MRK

📍 AVLP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVLPMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVLP + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AVLP pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVLP
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, AVLP beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVLP + MRK for your $10,000?

AVLP: 50%MRK: 50%
100% MRK50/50100% AVLP
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AVLP
No analyst data
Altman Z
-24.8
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVLP buys
0
MRK buys
0
No recent congressional trades found for AVLP or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVLPMRK
Forward yield500000.00%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$4.663521010693878e+33M$30.7K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$950.29
Total dividends collected$4.6634009849658873e+33M$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AVLP vs MRK ($10,000, DRIP)

YearAVLP PortfolioAVLP Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,192$351.54+$50.00MAVLP
2$233,748,371,262$233,694,859,813.08$12,524$392.70+$233748.36MAVLP
3$1,021,074,511,412,696$1,020,824,400,655,446.10$14,015$438.65+$1021074511.40MAVLP
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$15,682$489.96+$4168597328794.94MAVLP
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$17,547$547.23+$15905475114600664.00MAVLP
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$19,632$611.16+$56718938532531060736.00MAVLP
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$21,963$682.53+$1.8903180743562385e+23MAVLP
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$24,571$762.18+$5.8879981047651824e+26MAVLP
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$27,486$851.08+$1.7140642681147225e+30MAVLP
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$30,745$950.29+$4.663521010693878e+33MAVLP

AVLP vs MRK: Complete Analysis 2026

AVLPStock

Avalanche International, Corp., through its subsidiaries, operates a restaurant under the Giulia name. It also develops material synthesis technology for textile applications. The company was founded in 2011 and is based in Las Vegas, Nevada.

Full AVLP Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this AVLP vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVLP vs SCHDAVLP vs JEPIAVLP vs OAVLP vs KOAVLP vs MAINAVLP vs JNJAVLP vs ABBVAVLP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.